tirzepatide clinical trial results heart In the SUMMIT trial, researchers examined cardiovascular outcomes of treatment with in patients with Cardiovascular outcomes of semaglutide and

Prime released additional adherence findings earlier this year, which found a further 14% point decrease in persistence after two years

As in the LEAN study, the primary outcome is histologic resolution of NASH without worsening of fibrosis after 72 weeks of treatment, while secondary outcomes include improvement in liver fibrosis (1 stage) with no worsening of NASH, NAFLD activity score, as well as multiple serum markers of fibrosis

N., Fiorello, M

Gwny kierunek bada nad GHK-Cu dotyczy syntezy kolagenu i elastyny, poprawy struktury skry oraz redukcji oznak starzenia

- The addresses emotional eating, body image changes, stress management, anxiety, and the psychological adaptations that often accompany significant weight loss and health improvement